TABLE 3.
UC, N = 61 (55.5%) | |
---|---|
Treatment duration—weeks, Median (IQR) | 13 (7–34) |
Reason discontinuation, N (%) | |
No response | 36 (59) |
Adverse events | 11 (18) |
Secondary loss of response | 9 (14.8) |
Request patient | 2 (3.3) |
Death after euthanasia (non‐IBD related) | 1 (1.6) |
Long‐term biochemical remission | 1 (1.6) |
No effect on arthralgia | 1 (1.6) |